F1000Research 2019, 8:323 Last updated: 17 MAY 2019
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
PQDx 0141-051-00 WHO
PQDx Public Report
April/2017, version 5.0
PQDx 0181-031-00
WHO PQ Public Report
March/2017, version 3.0
PQDx 0159-055-00
WHO PQ Public Report
February/2017, version 5.0
WHO Progress Brief
Progress Brief
July 2017
International Journal of Infectious Diseases 80 (2019) 10–15
journal homepage: www.elsevier.com/locate/ijid
Research Article
Hindawi
BioMed Research International
Volume 2018, Article ID 9619684, 10 pages https://doi.org/10.1155/2018/9619684
COVID-19 is a disease caused by a new strain of coronavirus, a new coronavirus associated with the severe acute respiratory syndrome (SARS) viruses family and some coronaviruses associated with common cold.
There is still no evidence that persons living with HIV have a higher risk of contracting CO...VID-19 or if they will experience further complications of the disease, in case of contracting it. Nevertheless, it is very important that persons with HIV take all necessary precautions to prevent the spread.
more
The COVID-19 pandemic arrived in an evolving epidemiological context where some countries are experiencing a progressive decrease in HIV positivity in their testing programme as they are moving closer to the first 95 target. Distinguishing changes in HIV testing services due to the COVID-19 pandemic... from those resulting from evolving HIV testing strategies is crucial for adapting services and helping countries define their strategic mix of testing options moving forward. There is a need to focus, prioritize and plan for strategic efforts to prevent going further off the track toward achieving global targets and goals.
To support these efforts, WHO in partnership with ministries of health conducted an in-depth analysis of HIV testing services and antiretroviral therapy (ART) initiation prior to and during reported COVID-19 disruptions. Additional publicly available Global Fund and PEPFAR data was also reviewed and analysed. This analysis, and coordination with ministries of health, identified key service delivery adaptations utilized during COVID-19-related disruptions and formed the basis of this strategic guide.
This document focuses on current country needs, as well as plans for prioritization and potential surge support needs in the event of future disruptions. Although the data and implications are specific to sub-Saharan Africa, key principles and lessons can be applied elsewhere.
more